Cardiology pharmacology Flashcards
Drug therapy for AF
Anticoagulation
Rate control strategy
Rhythm control strategy
‘Pill in the pocket’
Rate control strategy
Beta blocker
Rate lowering calcium antagonist (verapamil, diltiazem)
Digoxin
Rhythm control strategy
Structural heart disease: beta blocker or amiodarone
No structural heart disease: beta blocker, felcainide
‘Pill in the pocket’
Flecainide
Propafenone
Digoxin
Used to treat AF
Rhythm control- attempting to control sinus rhythm
Increases the force of contraction and reduces conductivity with the AV node
Only effective for controlling the ventricular rate at rest
Dose should be determined on ventricular rate at rest
Digoxin monitoring
Renally excreted
Regular monitoring of plasma digoxin concentration is not required
Toxic levels from 1.5-3mcg/l
Toxicity increased by AKI, hypokalaemia, hypercalcaemia, hypomagnesaemia
Signs of digoxin toxicity
Lethargy
Confusion
Vomiting
Loss of appetite
Diarrhoea
Visual changes
Digoxin dosing
Loading dose can be given on any ward
IM administration is not recommended
Adult loading: 750mcg-1mg in divided doses over 24 hours, reduce dose if elderly
Adult maintenance dose: 125-250mcg OD
Amiodarone dosing
Need 5-10g in total load
IV amiodarone dose
5mg/kg loading dose given over 20-120 minutes with ECG monitoring
Infusion 1.2g/24 hours preferred central administration
Oral amiodarone dose
200mg TDS for 1 week then
200mg BD for 1 week then
200mg OD as maintenance dose
Bloods to check on amiodarone
LFTs
TFTs
Cardiac amiodarone side effects
Worsen arrhythmia or new arrhythmia
Skin amiodarone side effects
Sensitive to the sun and/ or blue grey discolouration
Eyes amiodarone side effects
Corneal deposits in the eye; take care with night driving
Thyroid amiodarone side effects
Under active thyroid disease
Over active thyroid disease
Blood tests before and then every 6 months
Liver amiodarone side effects
Rarely causes abnormal liver tests
Need blood test before starting then every 6 months